Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Genes, Chromosomes & Cancer|January 17, 2016
ALK-rearranged renal cell carcinomas in childrenMariana M Cajaiba, Lawrence J Jennings, Stephen M Rohan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2021
Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypesAndres M Acosta, Lynette M Sholl, Brendan C Dickson, et al.
British Journal of Cancer|May 4, 2016
Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapyMarieke A de Graaff, Marije A J de Rooij, Brendy E W M van den Akker, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 13, 2016
Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell lineYvonne de Jong, Annemiek M van Maldegem, Adrian Marino-Enriquez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2024
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L Haddox, Michael J Nathenson, Emanuele Mazzola, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
Aberrant AKT activation drives well-differentiated liposarcomaAlejandro Gutierrez, Eric L Snyder, Adrian Marino-Enriquez, et al.
The New England Journal of Medicine|April 4, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumorsMichelle A Maynard, Adrian Marino-Enriquez, Jonathan A Fletcher, et al.
Molecular Cancer Therapeutics|July 17, 2019
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1/2 Inhibition as Salvage StrategyThomas Mühlenberg, Julia Ketzer, Michael C Heinrich, et al.
The American Journal of Surgical Pathology|September 18, 2012
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangementCheng-Han Lee, Rola H Ali, Marjan Rouzbahman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)Matthew Ingham, Jacob B Allred, Li Chen, et al.
Pageof 3